EA5142 adjuvant nivolumab in resected lung cancers (ANVIL): The newest study in the ALCHEMIST platform Meeting Abstract
| Authors: | Chaft, J. E.; Dahlberg, S. E.; Gerber, D. E.; Oxnard, G. R.; Malik, S. M.; Simone, C. B.; Edelman, M. J.; Heymach, J.; Rudin, C. M.; Ramalingam, S. S. |
| Abstract Title: | EA5142 adjuvant nivolumab in resected lung cancers (ANVIL): The newest study in the ALCHEMIST platform |
| Meeting Title: | 53rd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 35 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2017 Jun 2-6 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2017-05-20 |
| Start Page: | 444s |
| Language: | English |
| ACCESSION: | WOS:000411932201152 |
| DOI: | 10.1200/JCO.2017.35.15_suppl.TPS8575 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS8575 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
